| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Regional Businesses | SVP, Regional Businesses | SVP, Group Executive Clin. Fran. +1 more
1 company
Doherty Catherine T. serves as an EVP, Regional Businesses at DGX. Across recent SEC filings that breaks down to 0 buys and 60 sells. Those positions are worth an estimated $13.8M at current prices.
Historically, Doherty Catherine T.'s trades have earned a middling insider score of 55/100 across 18 rated trades. Over a 12-month horizon, 35.3% of those trades were profitable, with an average 12-month return of -11.6%.
The biggest single holding is DGX (~$13.8M) as EVP, Regional Businesses. The recent filings there lean toward selling, a net 570,489 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2017 | DGX Quest Diagnostics Inc | SVP, Clin. Franchise Solutions | Sell | 1,615 | $94.65 | $152,858.14 | -2.2% | |
| Jan 30, 2017 | DGX Quest Diagnostics Inc | SVP, Clin. Franchise Solutions | Sale+OE | 80,000 | $90.58 | $7,246,362.28 | -51.0% | |
| May 27, 2016 | DGX Quest Diagnostics Inc | SVP, Clin. Franchise Solutions | Sale+OE | 47,334 | $77.27 | $3,657,308.84 | -38.2% | |
| Apr 25, 2016 | DGX Quest Diagnostics Inc | SVP, Clin. Franchise Solutions | Sale+OE | 29,550 | $74.45 | $2,199,916.35 | -27.8% |